Related Experiment Video
Updated: Aug 6, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia
Insights
Furosemide therapy can improve lung mechanics in infants with bronchopulmonary dysplasia (BPD). However, this diuretic treatment typically does not significantly improve gas exchange, indicating limited clinical benefit for respiratory support in BPD infants.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants.
- Furosemide is a diuretic often used in BPD, but its impact on gas exchange is debated.
- The relationship between improved lung mechanics and gas exchange in BPD infants treated with furosemide requires clarification.
Purpose of the Study:
- To investigate the short- and long-term effects of furosemide on lung mechanics and gas exchange in infants with severe BPD.
- To determine if improvements in lung mechanics correlate with improvements in gas exchange.
Main Methods:
- 16 oxygen-dependent, hypercarbic infants with severe BPD were studied.
- Measurements included transcutaneous PO2 and PCO2, esophageal pressure, airflow, and tidal volume.
- Infants were assessed before, 1 hour after, and after 6-10 days of furosemide therapy; a control group was also monitored.
Main Results:
- A single furosemide dose improved lung compliance.
- Prolonged therapy improved compliance and resistance in the group.
- Significant improvement in oxygenation occurred in only 6 of 16 infants; PCO2 was unaffected.
- Changes in gas exchange did not correlate with changes in lung mechanics.
Conclusions:
- Long-term furosemide therapy can enhance lung mechanical properties in infants with BPD.
- Gas exchange, a critical measure of respiratory function, is generally not improved by furosemide.
- The clinical significance of furosemide's effect on lung mechanics alone in BPD warrants further investigation.
Abstract:
Although furosemide improves lung mechanics in some infants with broncho-pulmonary dysplasia (BPD), this may not be important unless gas exchange also improves. To determine the relationship between improvement in mechanics and improvement in gas exchange, the short- and long-term effects of furosemide therapy were studied in 16 spontaneously breathing infants with severe BPD who were both oxygen dependent and hypercarbic (mean PCO2 54 +/- 11 torr). Each infant was examined at least three times: before furosemide therapy, 1 hour after the first dose of furosemide, and after a 6- to 10-day course. Ten of the 16 infants were also examined three times during a 7-day control period. Transcutaneous PO2 and PCO2, esophageal pressure, air flow, and tidal volume were measured. Pulmonary resistance, lung compliance, and the alveolar to skin PO2 difference were calculated. After a single dose of furosemide, only compliance significantly improved. After prolonged therapy, compliance, resistance, and oxygenation significantly improved in the group as a whole, but better oxygenation was achieved in only six of 16 infants. tcPCO2 was unaffected by long-term furosemide therapy, but in all infants with decreased tcPCO2 1 hour after a single dose, there was sustained decrease in PCO2 after prolonged therapy. Changes in gas exchange were not explained by changes in lung mechanics. These data indicate that long-term diuretic therapy can improve the mechanical properties of the lungs of spontaneously breathing infants with BPD, but that gas exchange is usually unaffected.
More Related Videos
Related Concept Videos
Breathing
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

